Hjem › Kreft (alle typer) › Virginia › Charlottesville
Kliniske studier for Kreft (alle typer) i Charlottesville, VA
13 studier for Kreft (alle typer) søker deltakere på steder i og rundt Charlottesville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruttererFase 3
- Quetzal Site 3, Charlottesville
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RekruttererFase 2/3
- University Of Virginia Health System, Charlottesville
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruttererFase 2
- UVA Center for Psychiatric Clinical Research, Charlottesville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- University of Virginia Health System, Charlottesville
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- University of Virginia Cancer Center, Charlottesville
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RekruttererFase 1/2
- University of Virginia Health System, Charlottesville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- University of Virginia, Charlottesville
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- University of Virginia Cancer Center, Charlottesville
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
RekruttererFase 2
- University of Virginia Health System, Charlottesville
GEMINI-NSCLC: NSCLC Biomarker Study
RekruttererObservasjonsstudie
- University of Virginia, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Charlottesville
A Study of NX-1607 in Adults With Advanced Malignancies
RekruttererFase 1
- University of Virginia, Charlottesville
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekrutterer
- University of Virginia Health System, Charlottesville
Kreft (alle typer)-studier i andre byer
- Houston, TX121 studier
- New York City, NY110 studier
- Boston, MA86 studier
- Los Angeles, CA73 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Durham, NC58 studier
- Washington, DC58 studier
- Chicago, IL51 studier
- Seattle, WA49 studier
- Atlanta, GA49 studier
- Arlington, VA48 studier
Andre studier i Charlottesville
- Ikke-småcellet lungekreft21 studier
- Akut myelogen leukemi16 studier
- Prostatakreft15 studier
- Metastatisk kreft13 studier
- Endometriekreft13 studier
- Lungekreft13 studier
- Hjertesvikt11 studier
- Eggstokkreft10 studier
- Kolorektal kreft10 studier
- Type 1-diabetes9 studier
- Brystkreft9 studier
- Pankreaskreft9 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.